Safety and Hemodynamic Effects of Sotatercept in WHO Group 1 Pulmonary Arterial Hypertension and Group 2 CpcPH-HFpEF: A Systematic Review and Meta-Analysis of Randomized Controlled Trials (AHA 2026) - Oct 8, 2026 - Abstract #MDP2388; Pres time: Nov 9, 2026; 10:59 AM - 11:04 AM; Location: Moderated Digital Poster 18‚ Clinical Science Zone 2; In-Person; No abstract available
Retrospective data • Review • Cardiovascular • Pulmonary Arterial Hypertension • Respiratory Diseases
|
|
Ahmad Ali; Danish Ali Ashraf; Roshaan Aziz; Asia Batool; Maham Fatima; Muhammad Hamza; Abdullah Hasanat; Muhammad Maaz Hassan; Momina Khalid; Nayab Magsi; Robert Mentz; Heba Nadeem; Mah Rukh; Muhammad Usman Siddique
|